GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment.

Qin Tong,Deyu Li, Yan Yin,Lifang Cheng,Shuming Ouyang

Journal of inflammation research（2023）

引用 0|浏览2

暂无评分

摘要

In this study, we found that GBP5 has the potential to be used as a biomarker of ICIs efficacy for SCLC patients. GBP5 is related to the quantity of inflammatory molecules, a high level of immune infiltration, and a highly activated immune response pathway.

查看译文

关键词

gbp5,small cell lung cancer,prognosis,tumor immune microenvironment,immune checkpoint inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要